Please assess the completion status of the following clinical trial:

Trial Title: A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Diabetes

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female Japanese subject aged 20-70 years (both inclusive)~* Japanese passport holder~* Japanese-born parents~* Type 2 diabetes mellitus (as diagnosed clinically) for at least 12 months~* Treated with insulin for at least 3 months~* Body Mass Index (BMI) maximum 33.0 kg/m\^2~* Glycosylated haemoglobin A1c (HbA1c) maximum 10.0%~* Fasting C-peptide below 1.0 nmol/L~Exclusion Criteria:~* Use of oral antidiabetic drugs (OADs) and/or glucagon like peptide-1 (GLP-1) receptor agonists (exenatide, liraglutide) within 3 months prior to screening~* Subject who has donated any blood or plasma in the past month or more than 500 mL within 3 months prior to screening~* Not able or willing to refrain from smoking and use of nicotine gum or transdermal nicotine patches during the inpatient period~* Supine blood pressure at screening (after resting for 5 min) minimum 180 mmHg for systolic and/or minimum 100 mmHg for diastolic

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- NN1250 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).